Event Guide
Sneak Peek at What's Inside...
Making Sense of the Myeloid Mess: Defining in vivo Functional States & Translating them In Vitro - Thomas Farber, Senior Principal Scientist, Pfizer
Who to Treat, When to Treat? Biomarkers & Disease Stage in Myeloid Therapeutics - Maija Hollmen, Chief Scientific Officer, Faron Pharmaceuticals
Targeting Myeloid Heterogeneity & Ferroptosis: Rethinking Suppression in Pre-Metastatic Niches - Dmitry Gabrilovich, Executive Director, Chief Scientist, AstraZeneca
Having trouble downloading the brochure? Let us know and we’ll email a copy straight to your inbox.
Who's on the Program?
